Zolpidem Tartrate Capsule
Product Images NDC 13668-775

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 13668-775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Zolpidem Tartrate Caps 7pt5mg 30s Bottle Label)

Label for Zolpidem Tartrate Capsules 7.5 mg, containing 30 capsules. The label shows the product name prominently with dosage strength, NDC 13668-775, and states it is for oral use and prescription only. Manufactured by Torrent Pharma Inc., New Jersey, and Umendica Laboratories Pvt. Ltd., India. It includes storage instructions, pharmacist warning, and mentions the presence of FD&C Yellow No. 5 as a color additive.*

FDA Label Image

"image Description" (Zolpidem Tartrate Caps Structure)

Chemical structure of Zolpidem Tartrate, showing the molecular arrangement of the Zolpidem molecule combined with tartaric acid components.*

FDA Label Image

"image Description" (Zolpidem Tartrate Caps Torrent Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.